Φορτώνει......
FDA efficiency for approval process of COVID-19 therapeutics
Coronavirus disease 19 (COVID-19) is an infection caused by the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The pandemic spread of SARS-CoV-2 has resulted in significant health, economic, and social ramifications. There are no U.S. Food and Drug Administration (FDA)-approved...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Infect Agent Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7705854/ https://ncbi.nlm.nih.gov/pubmed/33292374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13027-020-00338-z |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|